Back to bill feed
H.R. 1266 (119th Congress)Introduced
Sign in to get alerts

Combating Illicit Xylazine Act

Read the record. Not the rhetoric.

See how your representatives voted on this bill.

DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.

Alignment with your views

Sign in and take the values quiz to see how this bill lines up with what you've said.

Summary

AI-generated summary — verify against full text

The Combating Illicit Xylazine Act places xylazine, an animal sedative increasingly used illicitly in drug supplies, into Schedule III of the Controlled Substances Act. The bill defines xylazine and establishes exceptions for legitimate veterinary and government animal-control uses, while providing transition periods for manufacturers and practitioners to comply with new regulatory requirements. It also directs the Sentencing Commission to review sentencing guidelines for xylazine offenses and requires the Attorney General to report to Congress on xylazine trafficking and misuse.

Values analysis

Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.

How your representatives voted

Sign in to see how your representatives voted on this bill.